BAROSTIM NEO System in the Treatment of Heart Failure
Status:
Unknown status
Trial end date:
2021-08-11
Target enrollment:
Participant gender:
Summary
The purpose of this portion of study NCT01471860 is to assess the long-term safety and
efficacy of the BAROSTIM NEO System in Canadian study participants implanted with the device.